These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24769427)

  • 21. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.
    Robertson RP
    Discov Med; 2010 Feb; 9(45):132-7. PubMed ID: 20193639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus, hyperglycaemia and cancer.
    Simon D; Balkau B
    Diabetes Metab; 2010 Jun; 36(3):182-91. PubMed ID: 20554237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fermented papaya preparation as redox regulator in blood cells of beta-thalassemic mice and patients.
    Amer J; Goldfarb A; Rachmilewitz EA; Fibach E
    Phytother Res; 2008 Jun; 22(6):820-8. PubMed ID: 18384199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of Withania somnifera against oxidative stress and pancreatic beta-cell damage in type 2 diabetic rats.
    Anwer T; Sharma M; Pillai KK; Khan G
    Acta Pol Pharm; 2012; 69(6):1095-101. PubMed ID: 23285670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Feb; 234(2):1300-1312. PubMed ID: 30146696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation.
    Collard E; Roy S
    Antioxid Redox Signal; 2010 Sep; 13(5):599-606. PubMed ID: 20095880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and DNA damage in type-2 diabetic mice: Mechanistic and therapeutic strategies.
    Alam MM; Iqbal S; Naseem I
    Arch Biochem Biophys; 2015 Oct; 584():10-9. PubMed ID: 26319175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
    Poh ZX; Goh KP
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice.
    Alam MM; Meerza D; Naseem I
    Life Sci; 2014 Jul; 109(1):8-14. PubMed ID: 24946265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.
    Becker S; Dossus L; Kaaks R
    Arch Physiol Biochem; 2009 May; 115(2):86-96. PubMed ID: 19485704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
    Ladefoged M; Buschard K; Hansen AM
    APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms for oxidative stress in diabetic cardiovascular disease.
    Pennathur S; Heinecke JW
    Antioxid Redox Signal; 2007 Jul; 9(7):955-69. PubMed ID: 17508917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats.
    Prabakaran D; Ashokkumar N
    Biochimie; 2013 Feb; 95(2):366-73. PubMed ID: 23079336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.
    Palsamy P; Subramanian S
    J Cell Physiol; 2010 Aug; 224(2):423-32. PubMed ID: 20333650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus.
    Oomen PH; Kant GD; Dullaart RP; Tervaert JW; Reitsma WD; Smit AJ
    Scand J Clin Lab Invest; 2004 Apr; 64(2):119-27. PubMed ID: 15115249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Free-radical reactions in diabetes mellitus].
    Mrowicka M
    Pol Merkur Lekarski; 2005 Oct; 19(112):571-6. PubMed ID: 16379329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.